InnoFluidics is dedicated to enhancing bioprocessing accuracy and quality by directly measuring the biophysical properties of cells, rather than relying on indirect information from changes in the surrounding medium. This approach benefits BioPharma companies involved in vaccine and cell line production, as well as drug delivery. The company provides fast and accurate offline (and eventually on-line) multiparameter data collection in a single run.
In addition, InnoFluidics plans to leverage its proprietary technology for rare cell analysis and sorting in liquid biopsy. This microfluidics-based platform facilitates label-free collection of intact circulating tumor cells and real-time characterization. The technology will be extended to clinics, hospitals, research labs, and pharma companies, enabling swift and precise treatment monitoring, dynamic drug response analyses for personalized treatment, and advancements in anti-cancer drug development.
